Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
1
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
59:19
59:19
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
59:19
Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors, moderated by Dr Neil Love. Produced by Research To Practice. C…
…
continue reading
1
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
1:00:58
1:00:58
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:58
Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and se…
…
continue reading
1
Optimizing the Management of Dedifferentiated Liposarcoma
1:15:13
1:15:13
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:15:13
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
1:02:34
1:02:34
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:02:34
Prof Peter Schmid from the Barts Cancer Institute in London, United Kingdom, and Dr Sara Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, review clinical trials investigating the role of antibody-drug conjugate-mediated therapies in the treatment of metastatic breast cancer. CME information and select publications here…
…
continue reading
1
Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
2:03:22
2:03:22
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:03:22
Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates …
…
continue reading
1
Management of Metastatic Urothelial Bladder Cancer
30:45
30:45
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
30:45
Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
1:15:58
1:15:58
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:15:58
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, discusses recent advances in the treatment of breast cancer following the 2024 ASCO Annual Meeting, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
46:12
46:12
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
46:12
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52:36
52:36
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
52:36
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:23
1:01:23
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:01:23
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting, moderated by Dr Neil Love. Produced by Research To Practice. CME in…
…
continue reading
1
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:17
54:17
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
54:17
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Novel Agents and Strategies in Lung Cancer
1:01:43
1:01:43
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:01:43
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:03
1:02:03
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and s…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
59:35
59:35
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
59:35
Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
1:14:59
1:14:59
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:14:59
Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, summarizes risk factors and targeted therapy options for patients with HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
53:35
53:35
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
53:35
Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
1:00:53
1:00:53
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:53
Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 data sets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Optimizing the Identification of HER2-Low Breast Cancer
23:48
23:48
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
23:48
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
59:17
59:17
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
59:17
Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
47:34
47:34
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
47:34
Dr Jonathan W Goldman from UCLA Health in Santa Monica, California, summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
1:06:09
1:06:09
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:06:09
Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publicat…
…
continue reading
1
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
1:02:25
1:02:25
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:02:25
Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
1:02:36
1:02:36
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:02:36
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
1:00:49
1:00:49
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:49
Dr Joshua Brody from the Tisch Cancer Institute at Mount Sinai in New York, New York, Dr Ian W Flinn from OneOncology in Nashville, Tennessee, and Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss recent updates on available and novel treatment strategies for various lymphomas, moderated by Dr Neil L…
…
continue reading
1
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
1:03:58
1:03:58
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:03:58
Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Heather McArthur from UT Southwestern Medical Center in Dallas, Texas, summarize the evolution of biomarker-driven treatment approaches for triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and se…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
1:00:06
1:00:06
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:06
Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer
1:23:41
1:23:41
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:23:41
Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
2:35:49
2:35:49
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:35:49
Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
1:00:48
1:00:48
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:48
Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets, moderated by Dr Neil Love. Produced by Research To Practice. CME informat…
…
continue reading
1
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
1:02:31
1:02:31
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:02:31
Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting, moderated by Dr Neil Love. Produced by Research To Practice. CME infor…
…
continue reading
1
Key Presentations on Lymphoma from Recent Major Conferences
1:16:45
1:16:45
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:16:45
Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Bispecific Antibodies in the Management of Multiple Myeloma
42:08
42:08
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
42:08
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
33:54
33:54
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
33:54
Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
1:16:31
1:16:31
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:16:31
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
1:02:14
1:02:14
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:02:14
Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice. CME info…
…
continue reading
1
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
2:13:00
2:13:00
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:13:00
Drs Rita Nanda, Sara M Tolaney, Julia Foldi, Laura Huppert and Saba Shaikh discuss available and emerging research, patient cases from participating junior clinical investigators and senior clinical investigator perspectives on relevant research data informing clinical decision-making for patients with metastatic triple-negative breast cancer, mode…
…
continue reading
1
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
1:07:21
1:07:21
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:07:21
Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
59:39
59:39
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
59:39
Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
1:00:47
1:00:47
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:47
Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
1:37:05
1:37:05
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:37:05
Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
59:51
59:51
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
59:51
Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here…
…
continue reading
1
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
1:04:28
1:04:28
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:04:28
Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
37:19
37:19
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
37:19
Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
1:35:00
1:35:00
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:35:00
Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.על ידי Research To Practice
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
58:42
58:42
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
58:42
Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications her…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
1:00:56
1:00:56
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:56
Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publication…
…
continue reading
1
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
1:14:02
1:14:02
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:14:02
Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
1:01:37
1:01:37
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:01:37
Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To …
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
1:00:13
1:00:13
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:00:13
Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
1:19:45
1:19:45
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:19:45
Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy, moderated by Dr Neil Love. Produced by Research To Practice. CME information and sel…
…
continue reading